side effect tirzepatide Explained: The Future of Weight Management Tirzepatide Side Effects Timeline: When

MeAgain is better for GLP-1-first daily tracking, shots, food, symptoms, progress, and medication context in one app.

The approval gives Novo Nordisk a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly.

Check out the latest price action and daily performance update.

Discover why bariatric surgery delivers five times more weight loss than GLP-1 medications like Wegovy and Zepbound

Positive findings from a phase III trial of semaglutide in metabolic dysfunction-associated steatohepatitis (MASH) is moving Novo Nordisk A/S to expand the glucagon-like peptide-1 (GLP-1) agonists indications in the U.S

Obesity has emerged as one of the leading global drivers of gastrointestinal and metabolic disease, contributing substantially to the burden of metabolic dysfunction-associated steatotic liver disease (MASLD), gastroesophageal reflux disease (GERD), Barrett's esophagus, pancreatitis, colorectal neoplasia, and obesity-associated malignancies